These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26133067)

  • 1. P-Glycoprotein (ABCB1) limits the brain distribution of YQA-14, a novel dopamine D3 receptor antagonist.
    Liu F; Wang X; Li Z; Li J; Zhuang X; Zhang Z
    Chem Pharm Bull (Tokyo); 2015; 63(7):512-8. PubMed ID: 26133067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction.
    Liu F; Zhuang X; Yang C; Li Z; Xiong S; Zhang Z; Li J; Lu C; Zhang Z
    Biopharm Drug Dispos; 2014 Jul; 35(5):296-307. PubMed ID: 24647883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
    Kallem R; Kulkarni CP; Patel D; Thakur M; Sinz M; Singh SP; Mahammad SS; Mandlekar S
    Drug Metab Lett; 2012 Jun; 6(2):134-44. PubMed ID: 23061481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Pires N; Igreja B; Wright LC; Soares-da-Silva P
    Xenobiotica; 2015; 45(9):828-39. PubMed ID: 25915108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetration.
    Iusuf D; Teunissen SF; Wagenaar E; Rosing H; Beijnen JH; Schinkel AH
    J Pharmacol Exp Ther; 2011 Jun; 337(3):710-7. PubMed ID: 21378205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice.
    Erdő F; Nagy I; Tóth B; Bui A; Molnár É; Tímár Z; Magnan R; Krajcsi P
    Brain Res Bull; 2017 Jun; 132():232-236. PubMed ID: 28629814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
    Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Lin X; Skolnik S; Chen X; Wang J
    Drug Metab Dispos; 2011 Feb; 39(2):265-74. PubMed ID: 21051535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux.
    Pérez-Victoria JM; Cortés-Selva F; Parodi-Talice A; Bavchvarov BI; Pérez-Victoria FJ; Muñoz-Martínez F; Maitrejean M; Costi MP; Barron D; Di Pietro A; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3102-10. PubMed ID: 16940108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux.
    Dai H; Marbach P; Lemaire M; Hayes M; Elmquist WF
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1085-92. PubMed ID: 12604685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
    Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
    Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone.
    Kanaan M; Daali Y; Dayer P; Desmeules J
    Fundam Clin Pharmacol; 2009 Oct; 23(5):543-8. PubMed ID: 19656202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
    Bachmeier CJ; Trickler WJ; Miller DW
    Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of xenobiotic efflux transporters in resistance to vincristine.
    Huang RS; Murry DJ; Foster DR
    Biomed Pharmacother; 2008 Feb; 62(2):59-64. PubMed ID: 17583464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes Coloaded with Elacridar and Tariquidar To Modulate the P-Glycoprotein at the Blood-Brain Barrier.
    Nieto Montesinos R; Béduneau A; Lamprecht A; Pellequer Y
    Mol Pharm; 2015 Nov; 12(11):3829-38. PubMed ID: 26390138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.
    Bardelmeijer HA; Ouwehand M; Beijnen JH; Schellens JH; van Tellingen O
    Invest New Drugs; 2004 Aug; 22(3):219-29. PubMed ID: 15122069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of P-glycoprotein activity in the Blood-Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques.
    On NH; Chen F; Hinton M; Miller DW
    Pharm Res; 2011 Oct; 28(10):2505-15. PubMed ID: 21598079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice.
    Barraud de Lagerie S; Comets E; Gautrand C; Fernandez C; Auchere D; Singlas E; Mentre F; Gimenez F
    Br J Pharmacol; 2004 Apr; 141(7):1214-22. PubMed ID: 15023856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
    Zastre JA; Chan GN; Ronaldson PT; Ramaswamy M; Couraud PO; Romero IA; Weksler B; Bendayan M; Bendayan R
    J Neurosci Res; 2009 Mar; 87(4):1023-36. PubMed ID: 18855943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.